A Delaware jury found Masimo’s early smartwatch models infringed two of Apple’s design patents, awarding Apple $250 in damages. Apple’s goal was not monetary but aimed at blocking Masimo’s smartwatch sales.
However, the jury ruled Masimo’s current models did not infringe Apple’s patents, a win for Masimo.
Previously, Masimo won a U.S. International Trade Commission ruling to block Apple’s Series 9 and Ultra 2 watches over blood oxygen technology, which Apple has appealed. Masimo alleges Apple stole its pulse oximetry technology, while Apple claims Masimo used litigation to clear the market for its watches.
Read full article